Trials / Withdrawn
WithdrawnNCT01265225
Prognostic Value of Stem Cell Related Markers
Prognostic Value of Stem Cell Related Markers CD24, CD44, CD326 and EPCR, for Predicting Breast Cancer Recurrence in Tumor Stages 0-II
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- The Baruch Padeh Medical Center, Poriya · Other Government
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of the investigators study is to identify a prognostic marker that will evaluate the probability of recurrence in patients with stage 0-II breast cancer following surgery to remove the tumor.
Conditions
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2013-02-01
- Completion
- 2013-04-01
- First posted
- 2010-12-23
- Last updated
- 2013-12-24
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01265225. Inclusion in this directory is not an endorsement.